Skip to main content

Arteris, Inc. (AIP) Stock Forecast 2025 - AI Price Prediction & Analysis


Arteris, Inc. (AIP) AI Stock Price Forecast & Investment Analysis

Arteris, Inc. Stock Price Chart and Technical Analysis

Loading Arteris, Inc. interactive price chart and technical analysis...

Arteris, Inc. (AIP) - Comprehensive Stock Analysis & Investment Research

Deep dive into Arteris, Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Arteris, Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Arteris, Inc.: Arteris, Inc. operates in the Manufacturing sector, making it an emerging small-cap investment.

Arteris, Inc. (Stock Symbol: AIP) is a leading company in the Manufacturing sector , specifically operating within the Semiconductors & Related Devices industry.

The organization employs approximately 188 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Arteris, Inc.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Arteris, Inc.: With $65M in annual revenue and -49.4% net margin, the company demonstrates developing profitability.

Annual Revenue: $65 million generating a -49.4% net profit margin .

Market Capitalization: $769 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -49.3% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Arteris, Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Arteris, Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Arteris, Inc. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Arteris, Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Arteris, Inc.: Market positioning analysis based on available financial and operational metrics.

Arteris, Inc. strategically competes in the highly dynamic Semiconductors & Related Devices marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 64.5% gross margin, indicating strong pricing power and operational efficiency.

Arteris, Inc. (AIP) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Arteris, Inc. stock analysis.

Loading Arteris, Inc. comprehensive fundamental analysis and insider trading data...

Deep dive into Arteris, Inc.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Arteris, Inc. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Arteris, Inc.: With a P/E ratio of -10.44, the market sees the stock as potentially undervalued.

P/E Ratio -10.44x
P/B Ratio -85.51x
Market Cap $769M
EPS $-0.81
Book Value/Share $-0.12
Revenue/Share $1.51
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Arteris, Inc. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Arteris, Inc.: An ROE of -49.3% indicates room for improvement in shareholder value creation.

ROE -49.3%
ROA -20.9%
ROIC -45.2%
Gross Margin 64.5%
Operating Margin -46.4%
Net Margin -49.4%
EBT Margin -52.3%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Arteris, Inc.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Arteris, Inc.: A current ratio of 2.45 indicates strong liquidity.

Current Ratio 2.45x
Quick Ratio 2.24x
D/E Ratio 0.04x
Financial Leverage 2.36x
Interest Coverage -39.4x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Arteris, Inc.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Arteris, Inc.: Free cash flow of $-4M indicates cash challenges that need attention.

Operating Cash Flow $-3M
Free Cash Flow $-4M
Capital Spending $-1M
FCF/Sales -8.3%
CapEx/Sales 2.0%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Arteris, Inc. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Arteris, Inc.: An asset turnover of 0.38x suggests room for improvement in asset utilization.

Asset Turnover 0.38x
Receivables Turnover 5.2x
Fixed Assets Turnover 8.8x
Days Sales Outstanding 70 days
Payables Period 98 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Arteris, Inc.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Arteris, Inc.: With annual revenue of $65M, Arteris, Inc. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $65M
R&D Expense $44M
SG&A Expense $64M
Cost of Goods Sold $6M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 88%
Cash & Short-term Investments 73%
Total Liabilities 58%
Short-term Debt 1%
Accounts Receivable 7%
Dividend & Shareholder Information
Shares Outstanding 44M
Growth Metrics (YoY)
EPS Growth -9.8%

Latest Arteris, Inc. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Arteris, Inc. (AIP) stock price and investment outlook.

, source: Seeking Alpha

Good afternoon, everyone. And welcome to the Arteris First Quarter 2023 Earnings Call. Please note this call is being recorded and simultaneously webcast. All material contained in the webcast is sole ...

, source: Yahoo Finance

Based on the one-year price targets offered by 4 analysts, the average target price for Arteris Inc (NASDAQ:AIP) is $15.00, with a high estimate of $16.00 and a low estimate of $14.00. The average ...

, source: Yahoo Finance

Earnings call Arteris posted Q3 2025 revenue of $17.4M, up 18% YoY and 5% sequentially, exceeding guidance. ACV + royalties hit a record $74.9M, up 24% YoY. Management raised full-year guidance ...

Arteris, Inc. Competitors & Peer Analysis - Manufacturing Sector

Comparative analysis of Arteris, Inc. against industry peers and competitors in the Manufacturing sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AAOI Unlock Forecast - 30 Days FREE Trial $1786M -17.5x 3.2x
ADI Unlock Forecast - 30 Days FREE Trial $137735M 60.8x 4.1x
ADTTF Unlock Forecast - 30 Days FREE Trial $21295M x 0.2x
AIP Unlock Forecast - 30 Days FREE Trial $769M -10.4x -85.5x
ALAB Unlock Forecast - 30 Days FREE Trial $27232M 136.9x 21.4x
ALGM Unlock Forecast - 30 Days FREE Trial $5409M 277.1x 5.7x
ALMU Unlock Forecast - 30 Days FREE Trial $291M x 7.1x
AMAT Unlock Forecast - 30 Days FREE Trial $217348M 31.8x 11.1x
AMBA Unlock Forecast - 30 Days FREE Trial $3190M -17.3x 5.4x
AMD Unlock Forecast - 30 Days FREE Trial $354855M 107.3x 5.8x
AMKR Unlock Forecast - 30 Days FREE Trial $10686M 34.7x 2.5x
AOSL Unlock Forecast - 30 Days FREE Trial $642M -88.3x 0.8x
ARM Unlock Forecast - 30 Days FREE Trial $149930M 180.6x 20.2x
ASTI Unlock Forecast - 30 Days FREE Trial $6M -0.1x 2.2x
ATEYY Unlock Forecast - 30 Days FREE Trial $22860M x 0.2x
ATOM Unlock Forecast - 30 Days FREE Trial $78M -3.5x 4.1x
AVGO Unlock Forecast - 30 Days FREE Trial $1842713M 97.3x 73.9x
AXTI Unlock Forecast - 30 Days FREE Trial $555M -7.3x 3.1x
BEEM Unlock Forecast - 30 Days FREE Trial $35M -2.9x 1.3x
BZAI Unlock Forecast - 30 Days FREE Trial $264M x 202.3x
CRDO Unlock Forecast - 30 Days FREE Trial $31426M 148.3x 24.4x
CRUS Unlock Forecast - 30 Days FREE Trial $6587M 17.4x 3.2x
DIOD Unlock Forecast - 30 Days FREE Trial $2398M 37.4x 1.3x
DQ Unlock Forecast - 30 Days FREE Trial $11720M x 5.4x
ENPH Unlock Forecast - 30 Days FREE Trial $4089M 20.9x 4.1x
FORM Unlock Forecast - 30 Days FREE Trial $4453M 109.0x 4.4x
FSLR Unlock Forecast - 30 Days FREE Trial $27644M 19.7x 3.1x
FTCI Unlock Forecast - 30 Days FREE Trial $141M -8.3x 13.6x
GCTS Unlock Forecast - 30 Days FREE Trial $75M x -1.2x
GSIT Unlock Forecast - 30 Days FREE Trial $187M -4.5x 4.8x
GUER Unlock Forecast - 30 Days FREE Trial $24M x x
HIMX Unlock Forecast - 30 Days FREE Trial $2833M x 6.2x
HYSR Unlock Forecast - 30 Days FREE Trial $174M x 5.1x
ICG Unlock Forecast - 30 Days FREE Trial $181M x 1.4x
ICHR Unlock Forecast - 30 Days FREE Trial $607M -30.4x 0.9x
INDI Unlock Forecast - 30 Days FREE Trial $916M -8.3x 2.5x
INTC Unlock Forecast - 30 Days FREE Trial $197360M 996.8x 1.9x
IPGP Unlock Forecast - 30 Days FREE Trial $3450M 134.6x 1.6x
IPWR Unlock Forecast - 30 Days FREE Trial $32M -5.9x 3.2x
JKS Unlock Forecast - 30 Days FREE Trial $4490M x 0.5x
KLIC Unlock Forecast - 30 Days FREE Trial $2470M 11595.5x 3.0x
LAES Unlock Forecast - 30 Days FREE Trial $137M x 1.2x
LASR Unlock Forecast - 30 Days FREE Trial $1845M -10.7x 8.5x
LEDS Unlock Forecast - 30 Days FREE Trial $17M -3.6x 6.0x
LPTH Unlock Forecast - 30 Days FREE Trial $378M -8.8x 17.6x
LSCC Unlock Forecast - 30 Days FREE Trial $10783M 395.8x 15.3x
MAXN Unlock Forecast - 30 Days FREE Trial $129M x 3.0x
MCHP Unlock Forecast - 30 Days FREE Trial $35567M 28.8x 5.3x
MCHPP Unlock Forecast - 30 Days FREE Trial $27390M x 4.1x
MOBX Unlock Forecast - 30 Days FREE Trial $19M x 44.9x
MPWR Unlock Forecast - 30 Days FREE Trial $46146M 24.4x 12.9x
MRAM Unlock Forecast - 30 Days FREE Trial $197M 145.4x 3.0x
MRVL Unlock Forecast - 30 Days FREE Trial $86042M 34.8x 6.1x
MTSI Unlock Forecast - 30 Days FREE Trial $13711M 139.1x 10.3x
MU Unlock Forecast - 30 Days FREE Trial $266161M 31.2x 4.9x
MX Unlock Forecast - 30 Days FREE Trial $95M -3.9x 0.4x
MXL Unlock Forecast - 30 Days FREE Trial $1600M -4.6x 3.4x
NA Unlock Forecast - 30 Days FREE Trial $72M x 0.1x
NLST Unlock Forecast - 30 Days FREE Trial $211M -3.3x -3.3x
NVDA Unlock Forecast - 30 Days FREE Trial $4476706M 45.1x 37.7x
NVEC Unlock Forecast - 30 Days FREE Trial $331M 23.9x 5.5x
NVTS Unlock Forecast - 30 Days FREE Trial $1889M -15.1x 5.0x
NXPI Unlock Forecast - 30 Days FREE Trial $57991M 28.1x 5.8x
ON Unlock Forecast - 30 Days FREE Trial $22187M 69.5x 2.8x
OSIS Unlock Forecast - 30 Days FREE Trial $4516M 29.7x 4.8x
PENG Unlock Forecast - 30 Days FREE Trial $1153M 45.4x 2.9x
PLAB Unlock Forecast - 30 Days FREE Trial $1383M 12.8x 1.2x
POWI Unlock Forecast - 30 Days FREE Trial $2023M 112.8x 3.0x
PRSO Unlock Forecast - 30 Days FREE Trial $7M -0.1x 2.0x
PXLW Unlock Forecast - 30 Days FREE Trial $36M -1.7x -18.9x
QRVO Unlock Forecast - 30 Days FREE Trial $8328M 38.2x 2.4x
QUIK Unlock Forecast - 30 Days FREE Trial $106M -651.3x 4.3x
RBCN Unlock Forecast - 30 Days FREE Trial $7M 11.2x 2.3x
RMBS Unlock Forecast - 30 Days FREE Trial $10937M 47.8x 8.5x
SEDG Unlock Forecast - 30 Days FREE Trial $1902M -0.9x 4.0x
SEVCF Unlock Forecast - 30 Days FREE Trial $103M x x
SHLS Unlock Forecast - 30 Days FREE Trial $1330M 40.0x 2.3x
SITM Unlock Forecast - 30 Days FREE Trial $9189M -44.5x 8.3x
SKYT Unlock Forecast - 30 Days FREE Trial $878M 7.0x 4.6x
SLAB Unlock Forecast - 30 Days FREE Trial $4649M -18.2x 4.3x
SMTC Unlock Forecast - 30 Days FREE Trial $7348M 257.3x 12.9x
SMTK Unlock Forecast - 30 Days FREE Trial $8M x 1.3x
SODI Unlock Forecast - 30 Days FREE Trial $43M x 2.4x
SPCB Unlock Forecast - 30 Days FREE Trial $37M -0.9x 1.0x
STM Unlock Forecast - 30 Days FREE Trial $23353M x 1.3x
STMEF Unlock Forecast - 30 Days FREE Trial $21008M x 1.2x
SYNA Unlock Forecast - 30 Days FREE Trial $2969M 15.9x 2.1x
TE Unlock Forecast - 30 Days FREE Trial $919M x 4.9x
TSEM Unlock Forecast - 30 Days FREE Trial $12718M x 4.8x
TXN Unlock Forecast - 30 Days FREE Trial $166842M 33.1x 10.0x
TYGO Unlock Forecast - 30 Days FREE Trial $132M -0.9x 11.0x
UCTT Unlock Forecast - 30 Days FREE Trial $1195M -331.9x 1.7x
VIAV Unlock Forecast - 30 Days FREE Trial $4085M 268.8x 5.6x
VLN Unlock Forecast - 30 Days FREE Trial $171M x 1.6x
WOLF Unlock Forecast - 30 Days FREE Trial $3514M -1.3x 1.0x

Frequently Asked Questions - Arteris, Inc. Stock Forecast

How accurate are Arteris, Inc. stock predictions?

Our AI model shows a 32% Spearman correlation coefficient for AIP predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Arteris, Inc. stock price forecasts?

Our analysis considers Arteris, Inc.'s financial metrics, Manufacturing sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Arteris, Inc. a good investment in 2025?

Based on our AI analysis, Arteris, Inc. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Arteris, Inc. forecasts updated?

Arteris, Inc. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Arteris, Inc. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Arteris, Inc. stock.

My Portfolio

Investment Dashboard

Loading your portfolio...